Manufacturing

Meg Rivers is the former senior editor for 

Articles

Experts divulge where the industry is outsourcing most frequently, when companies should outsource more, and when performing tasks in-house might be best.

Deciding Where to Outsource in Biopharma Development and Manufacturing

WuXi STA is opening a new large-scale oligonucleotide and peptide manufacturing facility.

WuXi STA Opens a New Large-Scale Continuous Manufacturing Plant

MilliporeSigma and Lotte Group will collaborate on facility design and workforce training for a new biologics business unit in the US.

MilliporeSigma to Supply Lotte Biologics with Biologics Manufacturing Capabilities in US

Astellas Pharma has opened its new gene therapy manufacturing facility in Sanford, NC, which will support clinical- and commercial-scale manufacturing of AAV vectors for gene therapies.

Astellas Opens New US-based Large-Scale Gene Therapy Manufacturing Facility

The expansion at Seqirus’ Holly Springs, N.C., manufacturing facility will support the formulation and fill/finish of influenza vaccines.

Seqirus Announces Completion of $156 Million Expansion of Vaccine Manufacturing Facility

Feliza Mirasol is the science editor for 

Advances in genomics tools can lead to quicker biotherapeutic development.

Employing Genomics Tools to Accelerate Drug Development

Lonza and Israel Biotech Fund form a two-year agreement to support accelerated development and manufacture of biologics and small molecules.

Lonza, IBF Collaborate to Support Development and Manufacturing of Biologics and Small Molecules

AGC Biologics is investing in viral vector suspension technology at its new Longmont, Colo., facility.

AGC Biologics Adds Viral Vector Suspension Technology at New US Campus

Further development of nucleic acid-based therapeutics has been accelerated by the recent success of mRNA vaccines.

Shining a Spotlight on Nucleic Acid-Based Therapeutics

Complex hurdles complicate the development of emerging therapies.

Manufacturing, Biologics